Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Rating of “Hold” by Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus rating of “Hold” from the fifteen brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $26.8462.

Several brokerages recently weighed in on ACHC. Royal Bank Of Canada raised their target price on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. TD Cowen raised their target price on shares of Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN boosted its position in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new stake in Acadia Healthcare during the 4th quarter worth about $52,000. GAMMA Investing LLC boosted its position in Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after acquiring an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after acquiring an additional 5,203 shares during the period.

Acadia Healthcare Trading Up 1.0%

Acadia Healthcare stock opened at $27.69 on Tuesday. The firm has a 50 day simple moving average of $25.42 and a 200-day simple moving average of $20.81. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The stock has a market capitalization of $2.55 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 9.15 and a beta of 0.69. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s revenue was up 7.6% on a year-over-year basis. During the same period last year, the firm posted $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities research analysts expect that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.